Related Experiment Video
Updated: May 3, 2026

Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor
Published on: January 4, 2016
Farnesoid X receptor-Acting through bile acids to treat metabolic disorders
1Department of Integrative Medical Sciences Northeastern Ohio Universities College of Medicine 4209 State Route 44 Rootstown, OH 44272 yzhang@neoucom.edu.
Abstract:
Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily and plays an important role in maintaining bile acid, lipid and glucose homeostasis. Bile acids are endogenous ligands for FXR. However, bile acids may also activate pathways independent of FXR. The development of specific FXR agonists has provided important insights into the role of FXR in metabolism. Recent data have demonstrated that FXR is a therapeutic target for treatment of certain metabolic disorders. This review will focus on recent advances in the role of FXR in metabolic disease.
Insights
Farnesoid X receptor (FXR) regulates bile acid, lipid, and glucose balance. Targeting FXR offers a promising therapeutic strategy for metabolic disorders, with recent research highlighting its crucial role.
Area of Science:
- Endocrinology
- Metabolic Research
- Molecular Biology
Background:
- The Farnesoid X receptor (FXR) is a nuclear receptor vital for metabolic homeostasis.
- FXR regulates bile acid, lipid, and glucose metabolism.
- Bile acids, FXR's natural ligands, can also trigger FXR-independent pathways.
Purpose of the Study:
- To review recent advancements in understanding FXR's role in metabolic diseases.
- To highlight FXR as a potential therapeutic target for metabolic disorders.
Main Methods:
- Literature review of recent studies on FXR and metabolic disease.
- Analysis of data from FXR agonist development and their metabolic effects.
Main Results:
- FXR agonists have provided significant insights into FXR's metabolic functions.
- FXR plays a critical role in maintaining metabolic homeostasis.
- Emerging data support FXR as a viable therapeutic target.
Conclusions:
- FXR is a key regulator of bile acid, lipid, and glucose metabolism.
- Targeting FXR presents a promising avenue for treating metabolic disorders.
- Continued research into FXR mechanisms is essential for therapeutic development.
More Related Videos
08:42Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hepatic Drug Excretion: Influencing Factors
Pharmacogenomics: Identification of New Drug Targets
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...